2018 Volume 33 Issue 6 Pages 269-275
Central line-associated bloodstream infection (CLABSI) is an infection that is routinely observed and is a problem in the pain of the patients and medical care economy. In total, 278 cases were clinically judged as CLABSI during hospitalization for 3 years from January 2013 to December 2015. When CLABSI occurs, additional medical cost is incurred; however, as for by one, examines the additional treatment (antimicrobial agents, antifebriles, testing, and hospital charges). Also, we examined bacteria detected from catheter tip cultures and the infection related to the number of the lumen incidence of catheter. The mean days from CVC puncture to the infection onset were 20.1, and the additional days of hospitalization were an average of 7.4. The total cost was 49,933,000 yen, and the additional total medical expense for the 278 cases was an average of 179,000 yen; 35.0% of Staphylococcus aureus, coagulase-negative staphylococci infections 32.5%, number of the lumen were single; the tip culture detected bacteria was double, and a rate of infection was high in order of triple. Also, an estimated cost of 20 million yen was expected for 3 years when we considered replacing it before CLABSI onset as a supposition in PICC. An increase in CLABSI extends the length of hospital stay and increases the medical cost. Prevention is important, and we consider adaptation of the catheter custody sufficient and do it, and unnecessary catheter removes it early without detaining you. The associated medical staff needs prevention from CLABSI and education about infection measures. Of the medical person to "recover from CLABSI if catheter withdrawal" have an easy plan, but CLABSI can be fatal when aggravated.